Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Tesco is the UK’s biggest grocer again — and its FY26 results explain exactly why Aldi and Lidl should be paying attention
Read More Technology Industry News Thoma Bravo to acquire risk and regulatory reporting firm AxiomSL Thoma Bravo acquisition of AxiomSL : Private equity firm Thoma Bravo has agreed to acquire a controlling stake… byPallavi MadhirajuOctober 21, 2020
